The Impact of Post-Analytical Tools on New York Screening for Krabbe Disease and Pompe Disease
New York uses a two-tier assay to screen newborns for Krabbe disease and Pompe disease. Individual enzyme activities are measured in the first-tier, and specimens from newborns with low activity are reflexed to second tier Sanger sequencing of the associated gene. Using only this two-tiered approach...
Saved in:
Main Authors: | Monica M. Martin (Author), Ryan Wilson (Author), Michele Caggana (Author), Joseph J. Orsini (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Newborn Screening for Krabbe Disease and Other Lysosomal Storage Disorders: Broad Lessons Learned
by: Joseph J. Orsini, et al.
Published: (2017) -
Newborn Screening for Krabbe Disease: Status Quo and Recommendations for Improvements
by: Dietrich Matern, et al.
Published: (2024) -
Achieving Congruence among Reference Laboratories for Absolute Abundance Measurement of Analytes for Rare Diseases: Psychosine for Diagnosis and Prognosis of Krabbe Disease
by: Zackary Herbst, et al.
Published: (2020) -
Two-Tiered Newborn Screening with Post-Analytical Tools for Pompe Disease and Mucopolysaccharidosis Type I Results in Performance Improvement and Future Direction
by: Patricia L. Hall, et al.
Published: (2020) -
Peripheral Neuropathy in Krabbe's Disease
by: J Gordon Millichap
Published: (1997)